Learn how biosimilars are creating more RA treatment options at a lower cost in Canada and how they may impact rheumatology treatment policies.
Patient advocate Lene Andersen looks at some of the obstacles to getting the medications you need and offers tips to break down the barriers.
RA patients were apt to receive a biologic drug sooner if they lived in an urban area closer to a prescriber.
By 
By 
